Miami Cancer Institute targets two more proton therapy units
Written by Katya Maruri on January 9, 2018
As the Miami Cancer Institute at Baptist Health South Florida prepares to commemorate its first anniversary this month, Dr. Michael Zinner, the institute’s founding chief executive officer and executive medical director, points to incorporating proton therapy units, building up the institute’s electronic medical records and continuing its work with the Memorial Sloan Kettering Alliance as being integral components to the institute’s current and future success.
The institute, which officially opened doors to its 445,000-square-foot flagship facility on Jan. 26, 2017, offers patients a wide range of comprehensive clinical services.
Some of those services, Dr. Zinner said, include diagnostic imaging, infusion chemotherapy, plans for bone marrow transplantation, radiation therapies, including standard radiation, Gamma knife, TomoTherapy and proton therapy, a nationally renowned robotic surgery program with emphasis on gynecology-oncology and thoracic surgery, access to clinical trials and special programs and support for patients, family and friends.
As a result of these services, Dr. Zinner said, the institute has been able to reach its patient target within its first year.
“It’s been a spectacular year,” Dr. Zinner told Miami Today. “We officially hit our patient target of 870 unique patients a day in early December and have completed around 50 clinical trials with multiple affiliates, including Memorial Sloan Kettering.”
In addition to meeting patient targets and completing clinical trials, he said, “this year has really been all about moving into the new building, getting acclimated to our new environment and getting things online as efficiently and quickly as possible.”
Moving forward, though, Dr. Zinner said, “We are looking to add two more proton therapy units sometime this year to provide patients with more therapy options.”
The first proton therapy unit, he said, came online at the end of November and currently has a waiting list of 60 patients.
As for other objectives the institute hopes to implement, Dr. Zinner said, “we hope to create a cohesive comprehensive culture for patients and families, while incorporating cutting-edge technology to ensure that patients receive top-notch medical care.”
“At the end of the day,” he said, “it’s all about providing patients with an unparalleled patient experience that is focused on providing them with the best possible care and services.”